Renal Risk-Benefit Determinants of Recombinant Human Erythropoietin Therapy in the Remnant Kidney Rat Model - Hypertension, Anaemia, Inflammation and Drug Dose

AuthID
P-00K-7Q1
Document Type
Article
Year published
2016
Published
in CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, ISSN: 1440-1681
Volume: 43, Issue: 3, Pages: 343-354 (12)
Indexing
Publication Identifiers
Scopus: 2-s2.0-84959362940
Wos: WOS:000370847400009
Source Identifiers
ISSN: 1440-1681
Export Publication Metadata
Marked List
Info
At this moment we don't have any links to full text documens.